Roth Capital downgraded shares of BioDelivery Sciences International (NASDAQ:BDSI) from a buy rating to a neutral rating in a research note released on Friday, TheFlyOnTheWall.com reports. They currently have $20.00 target price on the stock. BioDelivery Sciences International, Inc. (NASDAQ:BDSI) belongs to Healthcare sector. Its weekly performance is 0.60%. On last trading day company shares ended up $16.84. BioDelivery Sciences International, Inc. (NASDAQ:BDSI) distance from … Continue reading Investors Are Watching : BioDelivery Sciences International, Inc. (NASDAQ:BDSI), United Continental Holdings, Inc. (NYSE:UAL), China Auto Logistic Inc. (NASDAQ:CALI), LCNB Corp. (NASDAQ:LCNB), UNFI